<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>716</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15603885</PubmedId>
            <Abstract>ICC-1132, a recombinant virus-like particle comprising of a modified hepatitis B core protein with a B cell (NANP) and two T cell epitopes of Plasmodium falciparum circumsporozoite protein (CSP), was administered i.m. as a single 50 microg dose in Seppic ISA 720 to 11 volunteers. Local reactogenicity and systemic side effects were acceptable with the predominant finding being mild pain at the injection site. This regimen induced anti-NANP antibodies in 10/11 and modest T cell responses. There was no evidence of protection from experimental challenge with P. falciparum sporozoites. Other formulations and/or multi-dose regimens will be required to enhance the immunogenicity and efficacy of ICC-1132.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>857-64</ArticlePages>
            <ArticleTitle>Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Walther</LastName>
                    <ForeName>Michael</ForeName>
                </Author>
                <Author>
                    <LastName>Dunachie</LastName>
                    <ForeName>Susanna</ForeName>
                </Author>
                <Author>
                    <LastName>Keating</LastName>
                    <ForeName>Sheila</ForeName>
                </Author>
                <Author>
                    <LastName>Vuola</LastName>
                    <ForeName>Jenni M</ForeName>
                </Author>
                <Author>
                    <LastName>Berthoud</LastName>
                    <ForeName>Tamara</ForeName>
                </Author>
                <Author>
                    <LastName>Schmidt</LastName>
                    <ForeName>Annette</ForeName>
                </Author>
                <Author>
                    <LastName>Maier</LastName>
                    <ForeName>Carolin</ForeName>
                </Author>
                <Author>
                    <LastName>Andrews</LastName>
                    <ForeName>Laura</ForeName>
                </Author>
                <Author>
                    <LastName>Andersen</LastName>
                    <ForeName>Rikke F</ForeName>
                </Author>
                <Author>
                    <LastName>Gilbert</LastName>
                    <ForeName>Sarah</ForeName>
                </Author>
                <Author>
                    <LastName>Poulton</LastName>
                    <ForeName>Ian</ForeName>
                </Author>
                <Author>
                    <LastName>Webster</LastName>
                    <ForeName>Daniel</ForeName>
                </Author>
                <Author>
                    <LastName>Dubovsky</LastName>
                    <ForeName>Filip</ForeName>
                </Author>
                <Author>
                    <LastName>Tierney</LastName>
                    <ForeName>Eveline</ForeName>
                </Author>
                <Author>
                    <LastName>Sarpotdar</LastName>
                    <ForeName>Pramod</ForeName>
                </Author>
                <Author>
                    <LastName>Correa</LastName>
                    <ForeName>Simon</ForeName>
                </Author>
                <Author>
                    <LastName>Huntcooke</LastName>
                    <ForeName>Angela</ForeName>
                </Author>
                <Author>
                    <LastName>Butcher</LastName>
                    <ForeName>Geoffrey</ForeName>
                </Author>
                <Author>
                    <LastName>Williams</LastName>
                    <ForeName>Jack</ForeName>
                </Author>
                <Author>
                    <LastName>Sinden</LastName>
                    <ForeName>Robert E</ForeName>
                </Author>
                <Author>
                    <LastName>Thornton</LastName>
                    <ForeName>George B</ForeName>
                </Author>
                <Author>
                    <LastName>Hill</LastName>
                    <ForeName>Adrian V S</ForeName>
                </Author>
            </Authors>
            <Affiliations>Nuffield Department of Clinical Medicine, Centre for Clinical Vaccinology and Tropical Medicine, Oxford University, Old Road, Headington, Oxford OX3 7LJ, UK. Michael.walther@ndm.ox.ac.uk.</Affiliations>
            <ArticleChemicalList>Epitopes, T-Lymphocyte;Malaria Vaccines</ArticleChemicalList>
            <ArticleMeshHeadingsList>Adult; Amino Acid Sequence; Animals; Epitopes, T-Lymphocyte(administration &amp; dosage; immunology); Erythrocytes(immunology; parasitology); Female; Hepatitis B virus(genetics; immunology); Humans; Malaria Vaccines(administration &amp; dosage; adverse effects; genetics; immunology); Malaria, Falciparum(immunology; parasitology; prevention &amp; control); Male; Plasmodium falciparum(immunology); Sporozoites(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>23</Volume>
                <Issue>7</Issue>
                <Title>Vaccine</Title>
                <Issn>1873-2518</Issn>
                <MedlineTa>Vaccine</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>P. falciparum NANP epitope</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NANPNANPNANP</LinearSequence>
                        <StartingPosition>129</StartingPosition>
                        <EndingPosition>140</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA29527.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5843</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>43242</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 3 and 4</LocationOfData>
                        <BCellId>7203</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNANPNANP</LinearSequence>
                                            <StartingPosition>129</StartingPosition>
                                            <EndingPosition>140</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNVDP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, T1 epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>11</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>11</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Following vaccination with ICC-1132, anti-NANP IgG antibodies was detected in all vaccinated volunteers at least for one time point ( from days 14 to 168).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NANPNANPNANPNANPNANP</LinearSequence>
                                        <StartingPosition>129</StartingPosition>
                                        <EndingPosition>148</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>8011</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNANPNANP</LinearSequence>
                                            <StartingPosition>129</StartingPosition>
                                            <EndingPosition>140</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNVDP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5843</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, T1 epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>125</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>ICC-1132 vaccine including this epitope did not protect healthy human from infecting P. falciparum as measured by the mean time to onset of parasitaemia and parasites number tested by PCR.</AssayComments>
                        </AssayInformation>
                        <Antigen>
                            <AntigenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849324</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNANPNANP</LinearSequence>
                                            <StartingPosition>129</StartingPosition>
                                            <EndingPosition>140</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNVDP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5843</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>recombinant CSP</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849323</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNANPNANP</LinearSequence>
                                            <StartingPosition>129</StartingPosition>
                                            <EndingPosition>140</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNVDP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5843</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NANPNANPNANP</LinearSequence>
                                        <StartingPosition>129</StartingPosition>
                                        <EndingPosition>140</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>P. falciparum T1 epitope</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NANPNVDPNANP</LinearSequence>
                        <StartingPosition>105</StartingPosition>
                        <EndingPosition>116</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA29527.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5843</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>43256</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1849567</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNVDPNANP</LinearSequence>
                                            <StartingPosition>105</StartingPosition>
                                            <EndingPosition>116</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <MhcAllele>
                            <MhcAlleleId>419</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>182</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>ICC-1132 vaccine including this epitope did not protect healthy human from infecting P. falciparum as measured by the mean time to onset of parasitaemia and parasites number tested by PCR.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849299</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNVDPNANP</LinearSequence>
                                            <StartingPosition>105</StartingPosition>
                                            <EndingPosition>116</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>324</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NANPNVDPNANP</LinearSequence>
                                        <StartingPosition>105</StartingPosition>
                                        <EndingPosition>116</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849303</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNVDPNANP</LinearSequence>
                                            <StartingPosition>105</StartingPosition>
                                            <EndingPosition>116</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>63</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NANPNVDPNANP</LinearSequence>
                                        <StartingPosition>105</StartingPosition>
                                        <EndingPosition>116</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849304</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNVDPNANP</LinearSequence>
                                            <StartingPosition>105</StartingPosition>
                                            <EndingPosition>116</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>419</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NANPNVDPNANP</LinearSequence>
                                        <StartingPosition>105</StartingPosition>
                                        <EndingPosition>116</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1849566</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNVDPNANP</LinearSequence>
                                            <StartingPosition>105</StartingPosition>
                                            <EndingPosition>116</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <MhcAllele>
                            <MhcAlleleId>63</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>182</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>ICC-1132 vaccine including this epitope did not protect healthy human from infecting P. falciparum as measured by the mean time to onset of parasitaemia and parasites number tested by PCR.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849543</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNVDPNANP</LinearSequence>
                                            <StartingPosition>105</StartingPosition>
                                            <EndingPosition>116</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>324</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849544</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNVDPNANP</LinearSequence>
                                            <StartingPosition>105</StartingPosition>
                                            <EndingPosition>116</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>63</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>8012</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNVDPNANP</LinearSequence>
                                            <StartingPosition>105</StartingPosition>
                                            <EndingPosition>116</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <MhcAllele>
                            <MhcAlleleId>324</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>182</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>ICC-1132 vaccine including this epitope did not protect healthy human from infecting P. falciparum as measured by the mean time to onset of parasitaemia and parasites number tested by PCR.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849545</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NANPNVDPNANP</LinearSequence>
                                            <StartingPosition>105</StartingPosition>
                                            <EndingPosition>116</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                        <SourceMolecule>
                                            <GenBankId>BAF42671.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>10407</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>ICC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and Universal T cell epitope (EYLNKIQNSLSTEWSPCSVT) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>419</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Universal T cell epitope (UTC) CSP326-345</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                        <StartingPosition>326</StartingPosition>
                        <EndingPosition>345</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA29527.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5843</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>15056</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849556</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                                            <StartingPosition>326</StartingPosition>
                                            <EndingPosition>345</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNVDPNANPNANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>CC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and T1 cell epitope (NANPNVDPNANP) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>353</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849307</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                                            <StartingPosition>326</StartingPosition>
                                            <EndingPosition>345</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNVDPNANPNANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>CC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and T1 cell epitope (NANPNVDPNANP) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>63</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                                        <StartingPosition>326</StartingPosition>
                                        <EndingPosition>345</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849316</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                                            <StartingPosition>326</StartingPosition>
                                            <EndingPosition>345</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNVDPNANPNANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>CC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and T1 cell epitope (NANPNVDPNANP) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>413</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                                        <StartingPosition>326</StartingPosition>
                                        <EndingPosition>345</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849554</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                                            <StartingPosition>326</StartingPosition>
                                            <EndingPosition>345</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNVDPNANPNANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>CC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and T1 cell epitope (NANPNVDPNANP) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>413</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849555</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                                            <StartingPosition>326</StartingPosition>
                                            <EndingPosition>345</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNVDPNANPNANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>CC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and T1 cell epitope (NANPNVDPNANP) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>52</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849553</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                                            <StartingPosition>326</StartingPosition>
                                            <EndingPosition>345</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNVDPNANPNANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>CC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and T1 cell epitope (NANPNVDPNANP) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>63</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849317</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                                            <StartingPosition>326</StartingPosition>
                                            <EndingPosition>345</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNVDPNANPNANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>CC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and T1 cell epitope (NANPNVDPNANP) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>52</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                                        <StartingPosition>326</StartingPosition>
                                        <EndingPosition>345</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>1849318</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>19-39 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                                            <StartingPosition>326</StartingPosition>
                                            <EndingPosition>345</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29527.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>ICC-1132 vaccine</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideSequence>NANPNVDPNANPNANPNANP</PeptideSequence>
                                        <PeptideModifications/>
                                        <PeptideSourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </PeptideSourceMolecule>
                                        <PeptideSourceOrganismId>5833</PeptideSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Seppic ISA 720</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>1 dose of 50 µg of the vaccine.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>CC-1132 vaccine is a virus-like particle comprising a recombinant hepatitis B core protein into which the epitope, three NANP repeats B cell epitope and T1 cell epitope (NANPNVDPNANP) of P. falciparum CSP derived from the NF 54 strain were inserted.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>353</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EYLNKIQNSLSTEWSPCSVT</LinearSequence>
                                        <StartingPosition>326</StartingPosition>
                                        <EndingPosition>345</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29527.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

